The phosphoinositide 3-kinase inhibitor ZSTK474 increases the susceptibility of osteosarcoma cells to oncolytic vesicular stomatitis virus VSVΔ51 via aggravating endoplasmic reticulum stress
Blockage of phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) signal pathway is effective to increase the cytotoxic effects of oncolytic virus on cancer cells, but the detailed mechanisms are still largely unknown. Based on this, the present study managed to investigate the anti-tumor effects...
Guardado en:
Autores principales: | Jinqiong Jiang, Weida Wang, Weineng Xiang, Lin Jiang, Qian Zhou |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Taylor & Francis Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7f7f9ca77fe64181b2293b2ca04fcf26 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Use of Oncolytic Viruses in the Treatment of Multiple Myeloma
por: Georgia Stewart, et al.
Publicado: (2021) -
Antiviral Innate Responses Induced by VSV-EBOV Vaccination Contribute to Rapid Protection
por: Andrea R. Menicucci, et al.
Publicado: (2019) -
Oncolytic Virotherapy
Publicado: (2016) -
The Evolution and Future of Targeted Cancer Therapy: From Nanoparticles, Oncolytic Viruses, and Oncolytic Bacteria to the Treatment of Solid Tumors
por: Kyle M. Pierce, et al.
Publicado: (2021) -
Exosomes loaded with programmed death ligand-1 promote tumor growth by immunosuppression in osteosarcoma
por: Lei Zhang, et al.
Publicado: (2021)